Results of the Phase III androgen deprivation therapy (ADT) clinical trial demonstrate that toremifene citrate 80mg compared to placebo built bone and prevented fractures, reduced hot flashes, and
The Fast trial will recruit a minimum of 30 patients from approximately five sites in the US. The study is scheduled to begin recruitment in April, 2008 and
Data from these studies showed that Xanafide (amonafide malate) triggered a similar level of apoptosis but with less DNA damage. While Xanafide targeted many of the same genes
Under the new agreement between LevTech, now a wholly-owned subsidiary of ATMI, and Sartorius Stedim, the LevTech disposable bag mixing system will be available through Sartorius Stedim as
This clinical trial is the second in a series of Phase II studies of ATX-101 in aesthetic applications and is aimed at assessing the safety and effectiveness of
The expansion builds on the success of the European collaborations in Cancer Research Program (CCRP), launched in April 2007. All of the researchers in the program are using
The product is currently approved and marketed in the UK, Italy, Spain, and Belgium. Eurand will make an up-front payment and commercial milestone payments to Chiesi Farmaceutici, primarily
This was the second of several regularly scheduled reviews by the data safety monitoring board (DSMB) that will occur over the duration of the trial. The purpose of
The product candidate provides an effective, once-daily treatment for moderate to severe restless legs syndrome (RLS). One pharmacokinetic (PK) study has been completed and data from a second
The goal of the program is to evaluate DelSite’s parenteral technologies. DelSite has also agreed to provide GelSite polymer and technical information concerning the optimal solubilization and mixing
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.